Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 22, 2020
The Resurgence of Antibody Drug Conjugates in Cancer Therapeutics: Novel Targets and Payloads
Valentina Boni, Manish R Sharma, Amita Patnaik
International Journal of Molecular Sciences
|
February 8, 2012
MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer?
Ruth Zarate, Valentina Boni, Eva Bandres, et al.
Expert Review of Anticancer Therapy
|
May 16, 2017
The future of oncology therapeutics
André Mansinho, Valentina Boni, María de Miguel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2019
Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology
Karen A Autio, Valentina Boni, Rachel W Humphrey, et al.
Current Opinion in Oncology
|
July 6, 2017
Immunotherapy-based combinations: current status and perspectives
María J de Miguel-Luken, André Mansinho, Valentina Boni, et al.
Molecular Cancer Therapeutics
|
July 22, 2010
miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation
Valentina Boni, Nerea Bitarte, Ion Cristobal, et al.
Cancer
|
June 20, 2020
Increased vulnerability of clinical research units during the COVID-19 crisis and their protection
Maria de Miguel, Bernard Doger, Valentina Boni, et al.
Investigational New Drugs
|
January 16, 2016
Pharmacokinetics, metabolism, and excretion of (14)C-labeled belinostat in patients with recurrent or progressive malignancies
Emiliano Calvo, Guru Reddy, Valentina Boni, et al.
World Journal of Gastroenterology
|
February 25, 2012
Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array
Ana Abajo, Nerea Bitarte, Ruth Zarate, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2012
Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer
Javier Rodríguez, Ruth Zarate, Eva Bandres, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 22, 2020
The Resurgence of Antibody Drug Conjugates in Cancer Therapeutics: Novel Targets and Payloads
Valentina Boni, Manish R Sharma, Amita Patnaik
International Journal of Molecular Sciences
|
February 8, 2012
MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer?
Ruth Zarate, Valentina Boni, Eva Bandres, et al.
Expert Review of Anticancer Therapy
|
May 16, 2017
The future of oncology therapeutics
André Mansinho, Valentina Boni, María de Miguel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2019
Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology
Karen A Autio, Valentina Boni, Rachel W Humphrey, et al.
Current Opinion in Oncology
|
July 6, 2017
Immunotherapy-based combinations: current status and perspectives
María J de Miguel-Luken, André Mansinho, Valentina Boni, et al.
Molecular Cancer Therapeutics
|
July 22, 2010
miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation
Valentina Boni, Nerea Bitarte, Ion Cristobal, et al.
Cancer
|
June 20, 2020
Increased vulnerability of clinical research units during the COVID-19 crisis and their protection
Maria de Miguel, Bernard Doger, Valentina Boni, et al.
Investigational New Drugs
|
January 16, 2016
Pharmacokinetics, metabolism, and excretion of (14)C-labeled belinostat in patients with recurrent or progressive malignancies
Emiliano Calvo, Guru Reddy, Valentina Boni, et al.
World Journal of Gastroenterology
|
February 25, 2012
Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array
Ana Abajo, Nerea Bitarte, Ruth Zarate, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2012
Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer
Javier Rodríguez, Ruth Zarate, Eva Bandres, et al.
Page
of 7